CD274 and neoplasm: As an inhibitory immune checkpoint protein, programmed cell death receptor ligand 1 (PD-L1) is predominantly expressed on tumor cells and antigen-presenting cells and is known to inhibit the killing effect of T cells on tumor cells (16).